[Reset osmostat syndrome - when hyponatremia become «a normal»: diagnostics, case report].

L I Astafyeva, I N Badmaeva, I S Klochkova, Yu G Sidneva, O I Sharipov, O A Gadjieva, B A Bashiryan, P L Kalinin, A Yu Lubnin, A N Konovalov
{"title":"[Reset osmostat syndrome - when hyponatremia become «a normal»: diagnostics, case report].","authors":"L I Astafyeva, I N Badmaeva, I S Klochkova, Yu G Sidneva, O I Sharipov, O A Gadjieva, B A Bashiryan, P L Kalinin, A Yu Lubnin, A N Konovalov","doi":"10.14341/probl13235","DOIUrl":null,"url":null,"abstract":"<p><p>Reset osmostat syndrome (ROS) is characterized by a change of normal plasma osmolality threshold (decrease or increase), which leads to chronic dysnatremia (hypo- or hypernatremia). We have described a clinical case of ROS and chronic hyponatremia in a patient with chordoid glioma of the III ventricle. It is known that the patient had previously been diagnosed with hyponatremia (131-134 mmol/l). She has not hypothyroidism and hypocorticism. There is normal filtration function of the kidneys was (CKD-EPI 91.7 ml/mi/1,73m2). Urine osmolality and sodium level were studied to exclude of concentration kidney function disorder. During first three days after removal of the tumor of the third ventricle (chordoid glioma, WHO Grade II), the sodium level decreased to 119 mmol/l. Repeated infusions of 200-300 ml hypertonic 3% sodium chloride solution, gluco- and mineralocorticoid therapy was ineffective, increasing plasma sodium levels by 2-3 mmol/l with the return to the initial level during 6-8 hours. Hypopituitary disorders did not develop after surgery. With further observation, the sodium level remained within 126-129 mmol/l for 6 months after surgery. The water load test make exclude the classic syndrome of inappropriate secretion of antidiuretic hormone, and confirmed the diagnosis of RSO. Because of absence of clinical symptoms associated with hyponatremia, no medical correction was required, patient was recommended to clinical follow-up.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"69 5","pages":"65-72"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680544/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy endokrinologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/probl13235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Reset osmostat syndrome (ROS) is characterized by a change of normal plasma osmolality threshold (decrease or increase), which leads to chronic dysnatremia (hypo- or hypernatremia). We have described a clinical case of ROS and chronic hyponatremia in a patient with chordoid glioma of the III ventricle. It is known that the patient had previously been diagnosed with hyponatremia (131-134 mmol/l). She has not hypothyroidism and hypocorticism. There is normal filtration function of the kidneys was (CKD-EPI 91.7 ml/mi/1,73m2). Urine osmolality and sodium level were studied to exclude of concentration kidney function disorder. During first three days after removal of the tumor of the third ventricle (chordoid glioma, WHO Grade II), the sodium level decreased to 119 mmol/l. Repeated infusions of 200-300 ml hypertonic 3% sodium chloride solution, gluco- and mineralocorticoid therapy was ineffective, increasing plasma sodium levels by 2-3 mmol/l with the return to the initial level during 6-8 hours. Hypopituitary disorders did not develop after surgery. With further observation, the sodium level remained within 126-129 mmol/l for 6 months after surgery. The water load test make exclude the classic syndrome of inappropriate secretion of antidiuretic hormone, and confirmed the diagnosis of RSO. Because of absence of clinical symptoms associated with hyponatremia, no medical correction was required, patient was recommended to clinical follow-up.

[重置渗透综合征-当低钠血症成为“正常”:诊断,病例报告]。
重置渗透压综合征(ROS)的特征是正常血浆渗透压阈值的改变(降低或增加),从而导致慢性钠血症(低钠血症或高钠血症)。我们已经描述了一个临床病例ROS和慢性低钠血症患者脊索样胶质瘤的第三脑室。已知患者先前被诊断为低钠血症(131-134 mmol/l)。她没有甲状腺功能减退和虚荣症。肾脏滤过功能正常(CKD-EPI 91.7 ml/mi/1,73m2)。研究尿渗透压和钠水平以排除浓缩性肾功能障碍。在切除第三脑室肿瘤(脊索样胶质瘤,WHO II级)后的头三天,钠水平降至119 mmol/l。反复输注高渗3%氯化钠溶液200 ~ 300 ml,糖皮质激素和糖皮质激素治疗无效,可使血浆钠水平升高2 ~ 3 mmol/l, 6 ~ 8 h后恢复到初始水平。术后未发生垂体功能障碍。进一步观察,术后6个月钠水平维持在126-129 mmol/l。水负荷试验排除了典型的抗利尿激素分泌异常综合征,证实了RSO的诊断。由于无与低钠血症相关的临床症状,不需要医学纠正,建议患者进行临床随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信